- Albania / Albania
- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- Denmark / Danmark
- Finland / Suomi
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Sweden / Sverige
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
LISBON, Portugal: This year, Nobel Biocare opened a new chapter for implant dentistry with the launch of new surfaces and the introduction of the new Nobel Biocare N1 implant system. Visitors to the 28th Annual Scientific Meeting of the European Association for Osseointegration (EAO 2019) will have the opportunity tomorrow to view these groundbreaking innovations and discover more about them during an engaging symposium and through interactive hands-on sessions.
Sharing their expertise at the industry symposium tomorrow will be Dr Tristan Staas and Prof. Gabor Tepper, two of the leading implant clinicians in Europe. They will provide exclusive insights into how Nobel Biocare N1 is set up to revolutionise patient care. In order to address some of the shortcomings of current protocols, the recently introduced system was designed from the ground up according to biological principles and keeping patient needs in mind. Going beyond this new implant design, Nobel Biocare N1 is also redefining site preparation with the introduction of the OsseoShaper, an innovative alternative to conventional drilling protocols. Experiences from over 24 months of clinical evaluations of the Nobel Biocare N1 concept with an early ambassador group have already indicated promising results in terms of the method’s effectiveness.
Embodying the Mucointegration concept, Nobel Biocare’s Xeal and TiUltra surfaces will be available on the Nobel Biocare N1 implant system from the start. With the help of their specially tailored surface chemistry and topography, the system’s implants and abutments will benefit from optimised tissue integration. These new surfaces are already available for Nobel Biocare’s On1 and Multi-unit Abutment, as well as for NobelActive and NobelParallel implants, and are backed by the latest evidence published in Clinical Implant Dentistry and Related Research.
During the symposium, Staas and Tepper will be joined by the world-renowned clinician Dr Paulo Maló from Portugal, who will demonstrate how the NobelPro Line helps clinicians to master even the most challenging cases and treat more edentulous patients. The Nobel Biocare-sponsored symposium will take place on 27 September from 5:15 p.m. to 7:15 p.m. in the main auditorium of the Lisbon Congress Centre. Attendance is free with registration for the congress, and visitors are invited to come early to secure their seats.
Attendees interested in developing their practices further can take part in two hands-on sessions held by Nobel Biocare on Friday. In addition to a morning session on immediate restorations led by Staas, Tepper will demonstrate in the afternoon how to achieve optimal primary stability for immediate restorations in all bone densities through different drill protocols.
Those who wish to attend the workshops are invited to visit the Nobel Biocare booth to find out whether seats are still available. For more information on Nobel Biocare activities at EAO 2019, as well as the company’s extensive offering of products and services, visit Booth C15 in Hall 2 or go to www.nobelbiocare.com/eao.